An extract of a plant’s fruit in Nigeria could protect against seizure and prevent brain degeneration. It could therefore be studied further for the development of a new antiepileptic drug.
Academic rigour, journalistic flair
Articles on Epilepsy
Displaying 21 - 40 of 58 articles
The jury’s still out on whether or not CBD relieves stress and anxiety.
About 470,000 children in the US have epilepsy. Promising advances are being made in the field of epilepsy treatment for children.
A study suggests that CBD could help treat people with opioid addiction. But before you go buy a bottle for any use, it’s important to know that it has been FDA-approved to treat only one disease.
New approach to preventing seizures proves effective in mice.
During epileptic seizures, neurons in the brain fire without rhyme or reason. New research identifies a possible way to wrest back control by stopping these signals before they can get started.
Can a ketogenic diet really help you lose weight? Here’s what the research says.
Medical cannabis in the UK? Don’t hold your breath.
Society persists in criminalising the use of cannabis but it is morally indefensible.
A drug made from a molecule produced from cannabis gained approval from the FDA on June 25. But the molecule, CBD, is decidedly different from some other ingredients in cannabis: It doesn’t result in a high.
As medicines, not all cannabis products are created equal.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
Governments in Africa have done little to institute policies that improve awareness and protect people who have epilepsy.
Neuroscience labs around the world may need to reevaluate some of their assumptions about whether what works in animals will really produce meaningful treatments for people.
It can be very hard for people to accept that they – or their family member – are not to blame for their mental illness. Seeing the evidence in a scan can make a difference.
Epilepsy affects around 70 million people globally, 80% live in developing countries. A shortage of specialists, equipment and drugs complicates effective treatment and management.
Brain chemicals could explain some of these experiences, but so could bullying and social isolation.
Simpler animal models can give researchers a much clearer picture of human diseases.
Our brains may be slower at making decisions than computers, but there is a massive evolutionary benefit to this tardiness.
With restrictions to cannabis loosening at the state level, research is badly needed to get the facts in order.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Laureate Professor in the Department of Medicine and Director of the Comprehensive Epilepsy Program at Austin Health, The University of Melbourne
-
Director of Paediatrics, Austin Health; NHMRC Practitioner Fellow; Senior Principal Research Fellow, The Florey Institute; Professor of Paediatric Neurology Research, The University of Melbourne
-
Professor of Neuroscience and Neurology, University of Virginia
-
Assistant Professor of Neurology, University of Colorado Anschutz Medical Campus
-
Postdoctoral Fellow in Neurology, University of Virginia
-
NHMRC Principal Research Fellow, Professor, and Group Leader, Institute for Molecular Bioscience, The University of Queensland
-
Professor of Electrical & Electronic Engineering, The University of Melbourne
-
Professor of Molecular Cell Biology, Royal Holloway University of London
-
Director, Centre for Integrated Preclinical Drug Development and Professor of Pharmacy, The University of Queensland
-
Professor in Medical Sciences, Deakin University
-
Senior Deputy Director, Florey, Neurologist Austin Health, Florey Institute of Neuroscience and Mental Health
-
NHMRC CJ Martin Fellow, King Group, Division of Chemistry & Structural Biology, Institute for Molecular Bioscience, The University of Queensland
-
PhD researcher, Cornell University
-
Adjunct Associate Professor, The University of Queensland
-
Director of the Institute of Behavioural Neuroscience, UCL
